IL6 and chronic kidney disease: Furthermore, CKD patients develop endotoxemia, characterized by elevated levels of endotoxin, IL-6, CRP and lipopolysaccharide-binding protein (LBP), which contributes to chronic inflammation and has been associated with higher left-ventricular mass index (LVMI) and subsequently left-ventricular dysfunction [43].